ArticleJournal of clinical pharmacology2017

Evaluation of Evolocumab (AMG 145), a Fully Human Anti-PCSK9 IgG2 Monoclonal Antibody, in Subjects With Hepatic Impairment.

John P Gibbs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.